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Prostaglandin Synthase-Mediated
Metabolism of Carcinogens and a Potential
Role for Peroxyl Radicals As Reactive
Intermediates
by Lawrence J. Marnett*
Prostaglandin-H synthase is unique among enzymes of the plant and animal kingdom in its ability to
biosynthesize and metabolize hydroperoxides. Its cyclooxygenase activity oxygenates polyunsaturated
fatty acids to hydroperoxy endoperoxides, and its peroxidase activity reduces the hydroperoxy group to
hydroxy groups. Higher oxidation states ofthe peroxidase oxidize reducing substrates to electron-deficient
derivatives that react with macromolecular nucleophiles. In the case of aromatic amines, the electron-
deficientderivativesaremutagenictobacterialandmammaliancells. 3-Dicarbonylcompounds andretinoic
acid are oxidized to carbon-centered radicals that react with 02 to form peroxyl free radicals. Peroxyl
radicals are the most stable oxy radicals and are able to diffuse some distance from the site of their
generation. Peroxyl radicals are also formed during lipid peroxidation and in the reaction of polyunsa-
turated fatty acid hydroperoxides with metal complexes and metalloproteins. Peroxyl radicals epoxidize
isolated doubled bonds ofcompounds such as 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene (BP-7,8-diol); 3,4-
dihydroxy-3,4-dihydrobenzo(a)anthracene; and aflatoxin B1. The epoxide products represent the ultimate
carcinogenic forms of the respective compounds. Techniques for quantitating the extent of peroxidase
dependent or peroxyl radical-dependent metabolism in vivo make use of differences in the structure or
stereochemnistry ofreactive intermediatesformedbyperoxidases relative tocytochromesP450. Differences
in the relative amounts ofhydrolysis products and DNA adducts derived from anti- and syn-dihydrodiole-
poxides following application ofBP-7,8-diol to mouse skin in vivo indicate peroxyl radicals play a signif-
icant role in metabolism of BP-7,8-diol in uninduced animals.
Introduction
Prostaglandin-H (PGH) synthase catalyzes the oxy-
genation of arachidonic acid to the hydroperoxy endo-
peroxide, PGG2, and the reduction of PGG2 to the hy-
droxy endoperoxide, PGH2 [Eq. (1)] (1-3). PGH
synthase is unique among all plant and animal peroxi-
dases because it has the ability to biosynthesize the
hydroperoxide substrate for its peroxidase activity.
There has been a great deal ofinterest in the possible
involvement of PGH synthase in the oxidative metab-
olism of drugs and carcinogens (4-7). The tissue dis-
tribution and mechanisms ofoxidation ofPGH synthase
are distinct from those exhibited by the principal drug-
metabolizing enzyme in animal tissue, cytochrome P-
450. This raises the possibility that PGH synthase
serves as an alternative metabolic activation enzyme to
the P-450 isoenzymes. There appears little chance that
PGH synthase plays a major role in systemic drug me-
tabolism; but it may be involved in tissue-specific pa-
thology by certain toxins or carcinogens. For example,
PGH synthase-dependent oxidation is implicated in
bladder carcinogenesis by aromatic amines and nitro-
furans and in teratogenicity by trimethadone (7,8).
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Properties of PGH Synthase
Other mammalian peroxidases carry out similar oxi-
dations to PGH synthase. Why, then, is there special
interest in this particular peroxidase? Figure 1 illus-
trates some of the influences on PGH synthase that
provide a partial answer to this question. The proffle of
polyunsaturated fatty acids in phospholipids and tri-
glycerides is sensitive to the makeup of the fat eaten
by particular individuals. Thus, there are dietary influ-
ences on the substrates that PGH synthase oxidizes.
The cyclooxygenase activity ofPGH synthase only ox-
idizes free fatty acids, the concentrations ofwhich are
very lowin most cells (9,10). Release ofsubstrate is the
limiting step in prostaglandin biosynthesis and is trig-
gered by the interaction of membrane-active agents
with the cell surface (11). This makes PGH synthase
and the oxidations it catalyzes exquisitely sensitive to
events at the plasma membrane. The oxygenation of
arachidonic acid by PGH synthase is potently inhibited
by a variety of nonsteroidal anti-inflammatory drugs.
In fact, it is generally believed that this inhibition ex-
plains the mechanism of anti-inflammatory activity of
such drugs. Aspirin is noteworthy among the well-
known anti-inflammatory agents because it inhibits
PGH synthase by selectively acetylating the hydroxyl
group ofSer'M (12).
Recent work establishes that the levels ofPGH syn-
thase in cells are sensitive to stimulation at the tran-
scriptional andtranslationallevelby avarietyofgrowth
factors and tumor promoters, including epidermal
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FIGURE 1. Modulation ofarachidonicacid metabolism andPGH syn-
thase. See text for details.
growth factor (EGF), transforming growth factor 1,
interleukin-1 (IL-1), tetradecanoylphorbolacetate, and
tumor necrosis factor (13-17). Enhanced expression of
the PGH synthase gene by EGF and IL-1 appear to
be inhibited by corticosteroids (18,19), which may ex-
plain the potent anti-inflammatory activity ofEGF and
IL-1. An alternative mechanism for rapid modulation
ofPGH synthase protein levels is supported by the re-
port that the half-life ofthe protein in rat muscle is less
than 10 min (20). This half-life implies rapid turnover
by proteolysis, but the proteases responsible and the
generality oftheir action in other tissues has not been
established. The summation ofthese observation iden-
tifies PGH synthase as an enzyme that triggers intra-
cellular oxidations in response to events at the cell sur-
face while demonstrating sensitivity to a variety of
physiological and pharmacological modulators.
The initial product ofPGH synthase action is the hy-
droperoxy endoperoxide PGG2. Its hydroperoxide
grouptriggersthefonnationofpotentoxidizingagents,
either metal-oxo derivatives of the heme prosthetic
group or oxygen radicals derived from the hydroperox-
ide (21,22). The endoperoxide group is metabolized to
prostaglandins and thromboxane, which are potent au-
tocrine andparacrine mediators ofcellresponses. PGG2
is also converted to malondialdehyde, which is a mu-
tagen and carcinogen (23-25). Although the emphasis
of this paper is on mechanisms of oxidation by PGH
synthase, which is usually associated with tumor initi-
ation, PGH synthase may also play an important role
in proliferative events such as those associated with
tumor promotion and progression (26).
PGH synthase is widely distributed in mammalian
tissue but is particularly abundant in accessory sex
glands, lung, and vasculature (27). PGH synthase is a
membraneproteinlocatedintheendoplasmicreticulum,
the nuclear membrane, and occasionally in the plasma
membrane (28,29). The enzyme purified from ovine or
bovine seminal vesicles is a homodimer of70 kDa sub-
units (30-38). Itcontains 3.5% carbohydrate ofthehigh
mannose type and variable amounts offerric protopor-
phyrin IX (Fe3+-PPIX) (39). The heme group is essen-
tial for both cyclooxygenase and peroxidase activities
but is readily lost during solubilization and chromatog-
raphy. Both activities are reconstituted following ad-
dition of Fe3+-PPIX, whereas reconstitution with
Mn3+-PPIX produces an enzyme with high cyclooxy-
genase but low peroxidase activity (40). There is some
disagreement about the stoichiometry ofheme binding,
butmost estimates place itbetween one and two hemes
perhomodimer(41,42). TheaminoacidsequenceofPGH
synthase is available from its cDNA sequence (43-45).
The open reading frame codes for 600 amino acids, of
which the first 24 represent a signal sequence that is
absentinthematureprotein. Computeranalysisreveals
no striking parallels to other functionally related pro-
teins. Speculation has been offered for the location of
membrane binding and heme binding regions of the
polypeptide (43,46).
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Hydroperoxide-Dependent
Oxidations
Cooxidation during arachidonic acid oxygenation re-
sults from interactions of PGG2 or other hydroperoxy
fatty acids with the heme prosthetic group ofPGH syn-
thase or other metals and metalloproteins in the cells.
The two general pathways of hydroperoxide reduction
by metal complexes are shown in Equations (2) and (3).
One-electron reduction of the hydroperoxide produces
an alkoxyl free radical and a ferryl-oxo complex that is
one redox equivalent above Fe3+-PPIX [Eq. (2)]. Two-
electron reduction of the hydroperoxide produces an
alkoxide ion and a ferryl-oxo complex that is two redox
equivalents aboveFe3+-PPIX [Eq. (3)]. Bothferryl-oxo
complexes and the alkoxyl free radical are potent oxi-
dizing agents. Studies with a diagnostic hydroperoxide
probe, 10-hydroperoxy-octadeca-8,12,-dienoic acid, es-
tablishthattheheme prosthetic groupofPGH synthase
reduces hydroperoxides by two electrons [Eq. (3)] (46).
The two-electron oxidized heme has been detected by
rapid scan spectrophotometry and appears electroni-
cally very similar to the higher oxidation state known
as compound I of horseradish peroxidase (47,48). The
prosthetic group of compound I contains a ferryl-oxo
complex (Fe4+-O) and a porphyrin cation radical (49).
ROOH + Mn+ - RO + Mn+l
ROOH + Mn+ - ROH + Mn+2
(2)
(3)
PGH synthase catalyzes a number ofoxidations that
appear similar to those of horseradish peroxidase, but
acomprehensive comparison ofthe substrate specificity
of the two enzymes has not been perforned. All the
available mechanistic information indicates PGH syn-
thase follows a classic peroxidase catalytic cycle (Fig.
2). Reduction of the hydroperoxide oxidizes the heme
to compound I. This internediate must be reduced by
two electrons to regenerate resting enzyme. Heme re-
duction occurs by either stepwise electron transfer or
what appears to be concerted oxygen transfer. Oxygen
transferisonlyobservedwithalkylarylsulfides(50,51).
Certain amines and phenols are excellent substrates
for electron transfer oxidation by peroxidases. Amines
produce cation radicals and phenols produce phenoxyl
radicals (52). Certain P-dicarbonyl compounds and po-
lyenes are oxidized to carbon-centered radicals by elec-
trontransferorhydrogenatomabstraction(53-55). The
fate of the one-electron oxidized derivatives of the re-
ductants determines the eventual products of the re-
action; for example, amine cation radicals dispropor-
tionate to iminium cations and the parent amine [Eq.
(4)] (56). The iminium compounds undergo subsequent
reactions such as hydrolysis. Phenoxyl radicals couple
to form biphenols that can be further oxidized to qui-
nonoid compounds [Eq. (5)] (52). Diamines and poly-
phenolic compounds (benzidine, catechol) are particu-
larlygood substrates and are oxidized toquinoneimines
and quinones, respectively (6,57,58). Some ofthe one-
electron oxidized derivatives ofthereducingsubstrates
or their metabolites (e.g., amine cation radicals, qui-
noneimines, and quinones) react with nucleophilic sites
on proteins and nucleic acids. This reaction has been
suggested to account for the toxicity/mutagenicity or
transforming activity of aromatic amines, nitrofurans,
and diethylstilbestrol (7,59-61).
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Peroxyl Free Radicals
In contrast to the reactions ofnitrogen- and oxygen-
centered radicals, carbon-centered radicals couple to
molecular oxygen to form peroxyl radicals (62). This is
a very important reaction because peroxyl radicals are
long-lived and capable ofepoxidation ofisolated double
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FIGURE 2. Peroxidase catalytic cycle.
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bonds. A particularly interesting example ofthis epox-
idation is provided by retinoic acid. Retinoic acid is a
potent inhibitor oftumor promotion in mouse sldn (63-
65) and is amoderately good reducing substrate forthe
peroxidase of PGH synthase (54). Retinoic acid is oxi-
dized to a carbon-centered radical that forms a peroxyl
radical [Eq. (6)]. This peroxyl radical then epoxidizes
another molecule of retinoic acid, producing equal
amounts of4-hydroxy retinoic acid and 5,6-epoxy reti-
noic acid [Eq. (7)] (54). The reactivity of retinoic acid
toward peroxyl radicals is quite high among a series of
polyenes we have tested. This makes retinoic acid an
excellent radical scavenger and antioxidant (66).
Whether this property contributes to its chemoprev-
entive activity is unknown.
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Peroxyl radicals are recognized as the principal me-
diators oflipid peroxidation, but they have been essen-
tially overlooked as mediators ofhydroperoxide-depen-
dent oxidations until recently (69,70). In contrast to
alkoxyl radicals and metal-oxo complexes, peroxyl rad-
icals are relatively stable and somewhat selective in
their reactions. The half-lives ofperoxyl radicals range
from 0.1 to 10 sec in the biological mileu (71). This half-
life means that peroxyl radicals are able to diffuse to
cellular locations remote from the site of their genera-
tion to effect oxidations. An important reaction ofper-
oxylradicals istheirabilitytoepoxidize olefins [Eq. (9)]
(72). It is not certain what endogenous cellular com-
pounds, if any, are epoxidized, but there is no doubt
xenobiotics andtheirmetabolites areepoxidizedbyper-
oxyl radicals (70).
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Another way to make carbon radicals and, therefore,
peroxylradicals, is the cyclingofpolyunsatured alkoxyl
radicals [Eq. (8)] (67). Alkoxylradicalsproducedby one-
electron reduction of polyunsatured fatty acid hydro-
peroxides are transformed to peroxyl radicals in mod-
erateyield, andthisaccountsfor asignificantproportion
of hydroperoxide-dependent oxidations catalyzed by
metal complexes and metalloproteins (68).
In addition to the anticarcinogen retinoic acid, per-
oxyl radicals epoxidize the procarcinogens 7,8-dihy-
droxy-7,8-dihydrobenzo(a)pyrene (BP-7,8-diol); 3,4-
dihydroxy-3,4-dihydrobenzo(a)anthracene; and afla-
toxin B1 (73-77). The epoxide products ofeach ofthese
reactions represent the ultimate carcinogenic forms of
the parent molecules [benzo(a)pyrene and benzo-
(a)anthracene for the first two compounds]. Peroxyl
radical-dependent epoxidation of BP-7,8-diol has been
detected during such diverse processes as PGH syn-
thase-dependent cooxidation, NADPH-dependent lipid
peroxidation, cumene hydroperoxide-dependent-lipid
peroxidation, hematin-catalyzed decomposition of po-
lyunsaturated fatty acid hydroperoxides, peroxidase-
dependent oxidation of ,-dicarbonyl compounds, and
peroxidase-dependent oxidation of bisulfite (74,76,78-
81). The common thread through these reactions is the
generation ofperoxyl free radicals.
Techniques for Quantitating
Hydroperoxide-Dependent
Oxidations
Quantitating the extent to which hydroperoxide-de-
pendent xenobiotic oxidations occur in intact cells or in
vivo requires specific methodology for each compound
ofinterest. In some cases, one can exploit the different
mechanisms of oxidation ofxenobiotics by peroxidases
compared to cytochrome P450 to design experiments
to detect peroxidase products. For example, aromatic
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monoamines are oxidized by peroxidases to radical cat-
ions that form different adducts to DNA than do the
nitrenium ions formed in cytochrome P450-dependent
reactions(82). Peroxidase-dependentadductshavebeen
detected in DNA from the urinary bladders ofdogs fed
3-naphthylamine (83). Unfortunately, the identities of
the adducts have not been elucidated, and their for-
mation appears quite variable. Thus, the generality of
the formation ofthe adducts is not certain.
Stereochemistry has been used to differentiate epox-
idation of polycycic hydrocarbon dihydrodiols by per-
oxylradicals andcytochromesP450(84). Figure3sum-
marizes the stereochemical considerations that make
this approach feasible. The (-)-enantiomer of BP-7,8-
diol is epoxidized to the (+)-enantiomer of the anti-
dihydrodiolepoxide by both peroxyl radicals and cyto-
chromes P450. In contrast, the (+)-enantiomer ofBP-
7,8-diol is epoxidized to the (-)-enantiomer ofthe anti-
dihydrodiolepoxide by peroxyl radicals, but to the (+)-
enantiomer of the syn-dihydrodiolepoxide by cyto-
chromes P450 (84). Dihydrodiolepoxides hydrolyze to
tetrahydrotetraols thatarereadilyseparablebyHPLC,
which enables one to quantitate the amounts ofthe dih-
ydrodiolepoxides produced and to identify the oxidant
responsible for their formation (85). Alternatively, one
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canisolateDNAmodifiedbyBP-7,8-dioloxidationprod-
ucts, hydrolyzeittodeoxynucleosideadducts, andquan-
titative the levels ofadducts produced byreaction with
the various dihydrodiolepoxide enantiomers and dias-
tereomers. By starting with commercially available
(+)-BP-7,8-diol, one can directly determine the per-
centage of epoxides produced by peroxyl radicals or
cytochrome P-450.
The stereochemical approach has been employed to
detectperoxylradical-dependentepoxidationofBP-7,8-
diol in rat liver microsomes, mouse sldn homogenates,
cultured fibroblasts, cultured hamster trachea, and
freshly isolated mouse epidermal cells (79,86-89). Fig-
ure 4 displays HPLC proffles of the products of (+)-
BP-7,8-diol oxidation by epidermal homogenates from
control female CD-1 mice and mice pretreated with the
cytochrome P450 inducer 3-naphthoflavone (86). Per-
oxyl radical products predominate in the uninduced an-
imals, whereascytochrome P-450productsaretheprin-
cipal metabolites in 3-naphthoflavone-pretreated
animals. This suggests that peroxyl radicals are impor-
tant contributors to BP-7,8-diol oxidation in the skin of
nornalanimals, whereascytochromeP-450hasprimacy
ininducedanimals. SinceBP-7,8-diolisatumorinitiator
in mouse skin but is not a cytochrome P-450 inducer, it
seemsperoxylradicalsplayasignificantroleinthemet-
abolic activation of BP-7,8-diol to an ultimate carcino-
genicforminatleastonetissuecommonlyusedtoassay
tumor initiators (86,89). These conclusions are sup-
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FIGURE 3. Comparison ofthe stereochemistry ofepoxidation ofBP-
7,-diol by cytochrome P450 and peroxyl radicals.
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FIGURE 4. Reverse-phase HPLC proffles of the tetraol hydrolysis
products forned after (+)-BP-7,8-diol epoxidation by mouse skin
homogenates. (TA)tranu-anti-tetraol, themajorhydrolysisprod-
uct of the (-)-anti-dihydrodiolepoxide; (CS) cis-syn-tetraol, the
major hydrolysis product ofthe (+)-syn-dihydrodiolepoxide; and
(TS) trans-syn tetraol, the minor hydrolysis product of the (+)-
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WI
9
OL10 L. J. MARNETT
ported by studies ofBP-7,8-diol metabolism to tetraols
or DNA adducts in mouse skin in vivo (86,90).
A common approach to detectingmetabolic pathways
is the use of specific inhibitors. Numerous compounds
inhibit the cyclooxygenase activity of PGH synthase
(91). These compounds do not block the peroxidase ac-
tivity oftheenzyme, butbypreventingPGG2synthesis,
they inhibit PGH synthase-dependent cooxidation.
Agents such as aspirin and indomethacin are quite use-
ful in determining the percentage oxidation ofa partic-
ular compound dependent on PGG2 biosynthesis. How-
ever, PGH synthase inhibitors do not block hydro-
peroxide synthesis by lipoxygenases or by lipid per-
oxidation. This fact makes PGH synthase inhibitors of
limited utility for diagnosing the overall contribution of
hydroperoxide-dependent oxidation to the metabolism
of a given compound, particularly in intact cells or in
vivo. For example, indomethacin does not inhibit oxi-
dationof(+)-BP-7,8-diolto(-)-anti-dihydrodiolepoxide
by freshly isolated mouse epidermal cells (89). Other
biochemical studies establish that the peroxides re-
sponsible for BP-7,8-diol oxidation in epidermis arise
from lipid peroxidation (89).
Even ifone does see inhibition ofoxidation ofa com-
pound by an inhibitor of PGH synthase, one must in-
terpret the observation with caution. In intact cells,
toxicity oralteration ofcellcyclekinetics canbe depress
theextentofmetabolismand/orDNAadductionwithout
actually inhibiting the oxidative reaction. Conclusions
abouttheroleofPGHsynthase cooxidationinxenobiotic
metabolism based on inhibitor studies should be sup-
ported byparallel studies ofthe effects ofthe inhibitors
on the metabolites and macromolecular adducts derived
from the test compounds.
Workonthisproject hasbeensupported overtheyearsbyresearch
grants from the American Cancer Society (BC-244 and FRA-243) and
the National Institutes of Health (GM 23642, CA 43209, CA 47479).
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